Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and